Article Sidebar
Views PDF: 156
ASSESSMENT OF TREATMENT OUTCOMES AND SOME RISK FACTORS FOR MORTALITY OF COMMUNITY-ACQUIRED PNEUMONIA CAUSED BY STAPHYLOCOCCUS AUREUS IN THE ELDERLY POPULATION
Main Article Content
Abstract
Objectives: Community-acquired pneumonia is a notable contributor to mortality from infectious diseases on a worldwide scale, especially in the older population. Staphylococcus aureus is a prevalent infection known to cause severe pneumonia, often leading to a high incidence of complications and fatality. The study's objective was to assess the treatment outcomes and some factors associated with mortality rates of Staphylococcus aureus pneumonia in older people. Subjects and method: A cross-sectional study was conducted with 93 patients diagnosed with Staphylococcus aureus pneumonia admitted to Can Tho Central General Hospital from April 2021 to May 2023. Results: The research results showed clinical outcomes including 30-day all-cause death rates and pneumonia-related complications were slightly higher in the age group over 60 compared to those aged 60 and under, but the difference was not statistically significant. After performing multivariate analysis, it was found that heart failure (OR = 5.68, 95% CI: 1.01-32.1, p = 0.049) and central nervous system disease (OR = 5.26, 95% CI: 1.32-20.9, p = 0.018) were found to be independent factors that increased the mortality rate in individuals aged over 60. Conclusion: Clinical practitioners should evaluate and manage comorbidities regarding heart failure and central nervous system diseases during treatment of Staphylococcus aureus pneumonia due to its elevated fatality rate, especially in old patients.
Article Details
Keywords
Staphylococcus aureus (S. aureus), community-acquired pneumonia (CAP), elderly patient, mortality.
References
2. Nguyễn Văn Thành. Viêm phổi cộng đồng. Thực hành nội khoa bệnh phổi. Nhà xuất bản Y học. Hà Nội. 2022;38-58.
3. Cho SJ, Stout-Delgado HW. Aging and lung disease. Annu Rev Physiol. 2020;82:433-459. doi: 10.1146/annurev-physiol-021119-034610.
4. Gillet Y, Vanhems P, Lina G, et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis. 2007;45(3):315-321. doi: 10.1086/519263.
5. Hu PJ, Pittet JF, Kerby JD, Bosarge PL, Wagener BM. Acute brain trauma, lung injury, and pneumonia: more than just altered mental status and decreased airway protection. Am J Physiol Lung Cell Mol Physiol. 2017;313(1):L1-L15. doi: 10.1152/ajplung.00485.2016.
6. Lee LN, Chou WR, Wang JY, et al. Characteristics and local risk factors of community-acquired and health-care-associated Staphylococcus aureus pneumonia. Sci Rep. 2022 Nov 4;12(1):18670. doi: 10.1038/s41598-022-23246-1.
7. Mancini D, Gibson GT. Impact of pneumonia in heart failure patients. J Am Coll Cardiol. 2021;77(16):1974-1976. doi: 10.1016/j.jacc.2021.03.010.
8. McDanel JS, Perencevich EN, Diekema DJ, et al. Association between microbial characteristics and poor outcomes among patients with methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study. Antimicrob Resist Infect Control. 2015;4:51. doi: 10.1186/s13756-015-0092-1.
9. Regunath H, Oba Y. Community-Acquired Pneumonia. StatPearls Publishing. Treasure Island, Florida. 2022.
10. Sharma-Kuinkel BK, Ahn SH, Rude TH, et al. Presence of genes encoding panton-valentine leukocidin is not the primary determinant of outcome in patients with hospital-acquired pneumonia due to Staphylococcus aureus. J Clin Microbiol. 2012;50(3):848-856. doi: 10.1128/JCM.06219-11.
11. Shen L, Jhund PS, Anand IS, et al. Incidence and outcomes of pneumonia in patients with heart failure. J Am Coll Cardiol. 2021;77(16):1961-1973. doi: 10.1016/j.jacc.2021.03.001.
12. Shorr AF, Myers DE, Huang DB, et al. A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia. BMC Infect Dis. 2013;13:268. doi: 10.1186/1471-2334-13-268.
13. Silva GC, Jiang L, Gutman R, et al. Mortality trends for veterans hospitalized with heart failure and pneumonia using claims-based vs clinical risk-adjustment variables. JAMA Intern Med. 2020;180(3):347-355. doi: 10.1001/jamainternmed.2019.5970.
14. Smit J, Adelborg K, Thomsen RW, Søgaard M, Schønheyder HC. Chronic heart failure and mortality in patients with community-acquired Staphylococcus aureus bacteremia: a population-based cohort study. BMC Infect Dis. 2016;16:227. doi: 10.1186/s12879-016-1570-7.
15. Thabet N, Shindo Y, Okumura J, et al. Clinical characteristics and risk factors for mortality in patients with community-acquired staphylococcal pneumonia. Nagoya J Med Sci. 2022;84(2):247-259. doi: 10.18999/nagjms.84.2.247.